Navigation Links
$100 million supercomputing program boosts Australian medical research capacity
Date:6/18/2008

Under a new Victorian Life Sciences Computation Initiative, The University of Melbourne in Melbourne Australia will host a $100 million supercomputing program and facility dedicated to life sciences.

The initiative will develop the most powerful supercomputer and leading computational biology facility dedicated to life sciences research in the world.

Funding of $50 million has been provided by the Victorian State Government, as announced by the Victorian Premier John Brumby at Bio2008 in San Diego, USA overnight.

The Hon. Theo Theophanous, Victorian Minister for Industry and Trade, Information and Communication Technology, and Major Projects detailed the State Government's vision for the project at a special media announcement at the University of Melbourne today.

Vice Chancellor Professor Glyn Davis explained how Australia's first life sciences dedicated supercomputer will impact Victorian researchers and where the program will be located at the University of Melbourne.

"As part of the initiative, the University of Melbourne will develop a Life Sciences Computation Centre to undertake the peak computing operations and provide computational biology expertise to the institutions throughout the Melbourne Parkville Precinct," said Professor Glyn Davis, Vice-Chancellor of the University of Melbourne.

Professor Davis says researchers from the Parkville Precinct, Monash University and other leading Victorian research institutions will have access to the peak computing facility, encouraging a collaborative approach to medical research.

"We are tremendously excited about the potential for this initiative to expand dramatically the State's and the University's capacity in bioinformatics, computational biology and advanced biomedical image analysis."

"The far reaching vision and scale of this initiative will combine Victoria's already globally competitive biomedical research capability with computational infrastructure specially designed for the life sciences, equal to the best in the world" said Professor Davis.

"Life sciences research is being transformed by the application of rapid advances in computational biology, powered by innovations in very high performance computers and data management, "said Professor James Angus, Dean of the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne.

"This will lead to major improvements in public health outcomes - particularly in the areas of cancer, cardiovascular and neurological disease, chronic inflammatory diseases, bone diseases and diabetes."

The University of Melbourne intends to call for expressions of interest for the Life Sciences Computation Centre and peak computing facility (PCF) in 2008, with the major PCF installations planned for 2009 and 2011.


'/>"/>

Contact: Rebecca Scott
rebeccas@unimelb.edu.au
61-383-440-181
University of Melbourne
Source:Eurekalert

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
3. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
4. 1.5 million children could be saved
5. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
6. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
9. £5 million investment in personalized medicines to cut patient deaths
10. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... A product of ... seem to derive a heart-protective benefit from eating soy foods, while others do not, ... men who are able to produce equol—a substance made by some types of “good” ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent ... those report that family members or friends have also commented about their poor ... loss wear hearing aids. One reason, suggested by 89 percent of American respondents, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Super-Sod will attend ... 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home Show ... , For the booth, grass seed plant manager Chris Roquemore constructed furniture from recycled ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Social media ... especially for hospitals and health systems. Smith & Jones’ delves into this insight and ... episode, President of Smith & Jones David Vener meets up with social media strategist ...
(Date:2/22/2017)... ... February 22, 2017 , ... BrightStar Care Charleston , a ... Medical University of South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, ... on Aging is a tremendous resource in our community. We are thrilled to participate ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 2017 Research and Markets has announced ... (Thermometers - Digital, Infrared, Mercury; Trend Indicator):Analysis By Region, By Country ... ... forecasted to grow at a CAGR of 5.33% during 2016-2021 ... infectious diseases along with surging demand of digital thermometer. Apart from ...
(Date:2/22/2017)... Feb. 22, 2017 Oncternal Therapeutics, Inc., ... both rare and common malignancies, today announced the ... The company intends to use the proceeds to ... and to advance preclinical development of a new ... is a first-in-class anti-ROR1 monoclonal antibody being developed ...
(Date:2/22/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced that KCP-400 (RgIA4), a potent antagonist ... robust chronic pain relief and disease modifying effects ... the a9a10 nAChR as a new, non-opioid target ... were reported online in the February 20 th ...
Breaking Medicine Technology: